Daan Willocx obtained his bachelor’s degree from the UHasselt and his master‘s degree from the KU Leuven. During his studies, he completed an internship at Janssen: Pharmaceutical Companies of Johnson & Johnson, where he worked on the design and synthesis of novel anti-cancer drugs. Since October 2020, he started his PhD at the HIPS under the supervision of Prof. Dr. Anna Hirsch. His PhD focuses on the design and synthesis of compounds targeting the MEP-pathway.